Radnet Inc. is a leading provider of outpatient diagnostic imaging services in the United States, specializing in advanced imaging techniques such as MRI, CT scans, and PET/CT scans
The company operates a network of imaging centers that utilizes state-of-the-art technology to deliver high-quality medical imaging services to patients and healthcare professionals. In addition to diagnostic services, Radnet is engaged in the development of innovative imaging solutions and continuous improvement of patient care, making significant contributions to the fields of radiology and healthcare delivery. Through its commitment to excellence, Radnet aims to enhance patient outcomes and support medical providers in making informed diagnoses.
Diagnostic imaging company RadNet (NASDAQRDNT) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 13.5% year on year to $477.1 million. On the other hand, the company’s full-year revenue guidance of $1.94 billion at the midpoint came in 1.2% below analysts’ estimates. Its GAAP profit of $0.07 per share was 40.7% below analysts’ consensus estimates.
Shares of Marvell Technology, Inc. (NASDAQMRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial results and issued weak Q1 guidance.
